Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.75 HKD | +6.04% | +4.28% | -23.12% |
Apr. 30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
Apr. 29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bearish | Bearish |
Resistance | 36.20 | 40.20 | 40.10 |
Spread/Res. | +4.28% | -6.09% | -5.86% |
Spread/Supp. | +17.60% | +37.52% | +37.52% |
Support | 32.10 | 27.45 | 27.45 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 2162 Stock
- Charts Keymed Biosciences Inc.